IP Library Patent Application 16151144
Patent Application
App. No. 16/151,144

BIFUNCTIONAL POLYPEPTIDES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/151,144
Abstract

A bifunctional polypeptide comprising a specific binding partner for a peptide-MHC epitope, such as an antibody or T cell receptor, and an immune effector, such as an antibody or a cytokine, the immune effector part being linked to the N-terminus of the peptide-MHC binding part.

Claims (12)

1 .- 13 . (canceled)

14 . A bifunctional molecule, comprising:

a heterodimeric αβ T-Cell Receptor (αβTCR) or a single chain T-Cell Receptor (scTCR) comprising a TCR α or TCR β constant region, wherein the αβ TCR or the scTCR binds specifically to a given pMHC epitope, and

(ii) an immune effector polypeptide,

wherein:

the N-terminus of the α chain or the β chain of the αβ TCR, or the N-terminus of the scTCR, is linked to the C-terminus of the of the immune effector polypeptide, and

the effector polypeptide is a cytokine which modulates lymphocyte immunosuppressive or immunostimulatory activity.

15 . The bifunctional molecule of claim 14 , wherein the cytokine is selected from the group consisting of: IL-1, IL-la, IL-3, IL-4, IL-5, IL-6, IL-7, IL-10, IL-11, IL-12, IL-13, IL-15, IL-21, IL-23, TGF-β, IFN-γ, and TNFα.

16 . The bifunctional molecule of claim 15 , wherein the cytokine is IL-4.

17 . The bifunctional molecule of claim 15 , wherein the cytokine is IL-13.

18 . The bifunctional molecule of claim 15 , wherein the cytokine is TNF-α.

19 . The bifunctional molecule of claim 15 , wherein the cytokine is IFN-γ.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Nov 11, 2024
From: BIOPHARMA CREDIT PLC
To: IMMUNOCORE LIMITED
Reel/Frame 069197/0672 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2022
From: OXFORD FINANCE LUXEMBOURG S.À R.L
To: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
Reel/Frame 061916/0493 →
PATENT SECURITY AGREEMENT Recorded Nov 8, 2022
From: IMMUNOCORE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 061899/0866 →
SECURITY INTEREST Recorded Nov 6, 2020
From: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
To: OXFORD FINANCE LUXEMBOURG S.À R.L., REGISTERED WITH THE LUXEMBOURG COMMERCIAL REGISTER UNDER NUMBER B243395, ACTING IN RESPECT OF ITS COMPARTMENT 1
Reel/Frame 054344/0218 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2018
From: JAKOBSEN, BENT KARSTEN; VUIDEPOT, ANNELISE BRIGITTE; LI, YI
To: IMMUNOCORE LIMITED
Reel/Frame 047073/0370 →